نتائج البحث - "Langley, Richard"

1

دورية

Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab

المؤلفون: Blauvelt, Andrew, Pink, Andrew, Worm, Margitta, Langley, Richard G. B., Elewski, Boni E., Gjerum, Le, Guttman-Yassky, Emma

المصدر: JAMA Dermatology; November 2022, Vol. 158 Issue: 11 p1327-1330, 4p

2

دورية

Power Spectral Characteristics of In‐Situ Irregularities and Topside GPS Signal Intensity at Low Latitudes Using High‐Sample‐Rate Swarm Echo (e‐POP) Measurements

المؤلفون: Mohandesi, Ali, Knudsen, David J., Skone, Susan, Langley, Richard B., Yau, Andrew W.

المصدر: Radio Science; May 2024, Vol. 59 Issue: 5

3

دورية

Guselkumab Reduces Disease- and Mechanism-Related Biomarkers More Than Adalimumab in Patients with Psoriasis: A VOYAGE 1 Substudy

المؤلفون: Blauvelt, Andrew, Langley, Richard G., Branigan, Patrick J., Liu, Xuejun, Chen, Yanqing, DePrimo, Samuel, Ma, Keying, Scott, Brittney, Campbell, Kim, Muñoz-Elías, Ernesto J., Papp, Kim A.

المصدر: JID Innovations; September 2024, Vol. 4 Issue: 5

النص الكامل

4

دورية

Navigator Notes

المؤلفون: Langley, Richard B.

المصدر: Navigation; June 2021, Vol. 68 Issue: 2 p239-242, 4p

النص الكامل

5

دورية

Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial

المؤلفون: Reich, Kristian, Papp, Kim A, Blauvelt, Andrew, Langley, Richard G, Armstrong, April, Warren, Richard B, Gordon, Kenneth B, Merola, Joseph F, Okubo, Yukari, Madden, Cynthia, Wang, Maggie, Cioffi, Christopher, Vanvoorden, Veerle, Lebwohl, Mark

المصدر: The Lancet; February 2021, Vol. 397 Issue: 10273 p487-498, 12p

6

دورية

Differential Pharmacodynamic Effects on Psoriatic biomarkers by Guselkumab Versus Secukinumab Correlate With Long-term Efficacy: an ECLIPSE substudy

المؤلفون: Blauvelt, Andrew, Chen, Yanqing, Branigan, Patrick J., Liu, Xuejun, DePrimo, Samuel, Keyes, Brice, Leung, Monica, Fakharzadeh, Steven, Yang, Ya-Wen, Muñoz-Elías, Ernesto J., Krueger, James G., Langley, Richard G.

المصدر: JID Innovations; 20240101, Issue: Preprints

النص الكامل

7

دورية

Residual Lesional Gene Expression in Psoriasis Patients with Complete Skin Clearance Treated with Guselkumab or Adalimumab in VOYAGE 1 and 2

المؤلفون: Blauvelt, Andrew, Gordon, Kenneth B., Langley, Richard G., Branigan, Patrick J., Chen, Yanqing, Miller, Megan, Han, Chenglong, Fakharzadeh, Steven, Muñoz-Elías, Ernesto J., Armstrong, April W.

المصدر: Journal of Investigative Dermatology; 20240101, Issue: Preprints

8

دورية

Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline PASI from week 4-40

المؤلفون: Langley, Richard G., Sanyal, Chiranjeev, Situ, Aaron, Alulis, Sarah, Hassan, Fareen, Peterson, Steve, Teneralli, Rachel E., Lee, Jennifer, Patel, Barkha P., Disher, Tim

المصدر: JAAD International; 20240101, Issue: Preprints

النص الكامل

9

دورية

Navigator Notes

المؤلفون: Langley, Richard B.

المصدر: Navigation; September 2020, Vol. 67 Issue: 3 p447-450, 4p

النص الكامل

10

دورية

Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical Trial

المؤلفون: Blauvelt, Andrew, Leonardi, Craig L., Gooderham, Melinda, Papp, Kim A., Philipp, Sandra, Wu, Jashin J., Igarashi, Atsuyuki, Flack, Mary, Geng, Ziqian, Wu, Tianshuang, Camez, Anne, Williams, David, Langley, Richard G.

المصدر: JAMA Dermatology; June 2020, Vol. 156 Issue: 6 p649-658, 10p

تنقيح النتائج